在AML中通过SUCLG2-AS1-miR-17-5p-JAK1轴对m6A修改WTAP的调控功能和机制研究
Miaomiao Liu1, Bingxin Yu2, Yong Tian3
1Department of Pathogenobiology, The Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medicine, Jilin University, No.126 Xinmin Street, Changchun, Jilin, 130021, P.R. China.
BMC cancer
|January 17, 2024
概括
研究人员发现了一条涉及WTAP,SUCLG2-AS1,miR-17-5p和JAK1的新途径,该途径驱动急性髓性白血病 (AML) 的发展. 这一发现为AML治疗提供了潜在的新治疗点.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 急性髓性白血病 (AML) 是一种血癌,其特征是未成熟的细胞过度生长.
- 黄金白血病发展的确切原因和机制尚不清楚.
- 识别新的分子通路对于开发有效的AML疗法至关重要.
研究的目的:
- 阐明导致急性髓性白血病 (AML) 发展的分子机制.
- 在AML中识别和描述一种新的竞争性内源性RNA (ceRNA) 调控轴.
- 调查RNA甲基化在AML病变发生中的作用.
主要方法:
- 生物信息学分析以确定SUCLG2-AS1-miR-17-5p-JAK1 ceRNA轴.
- 露西法酶报告员和RIP测定验证RNA相互作用.
- 测量MeRIP-qPCR和m6ARNA甲基化量,以评估RNA甲基化.
- 在AML患者样本中分析WTAP的表达.
主要成果:
- 过度表达SUCLG2-AS1抑制了AML细胞的增殖,迁移和入侵,同时促进了细胞亡.
- SUCLG2-AS1作为miR-17-5p的ceRNA,导致JAK1的下调.
- 在AML细胞中,SUCLG2-AS1表现出由WTAP调节的m6ARNA甲基化增加.
- 在AML中WTAP的表达很高,并且与预后不佳有关.
结论:
- WTAP-SUCLG2-AS1-miR-17-5p-JAK1轴是反洗钱发展的组成部分.
- 通过WTAP介导的SUCLG2-AS1的m6A修饰在AML的发病过程中起着关键作用.
- 这个轴代表了急性髓性白血病的一个有前途的新型治疗点.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Regulation of Expression at Multiple Steps
913
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
913
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
tRNA Activation
19.3K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
19.3K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


